Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Tourette Syndrome

• Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
• Ecopipam Tablets to Study Tourette's Disorder in Children and Adolescents
• A Study to Explore the Effect of Sepranolone in Tourette Syndrome
• Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? A Pilot Study
• SCI-110 in the Treatment of Tourette Syndrome
• Pimavanserin Treatment in TS
• D-cycloserine Augmented Treatment for Youth With Tic Disorders
• Atomoxetine in Patients With Tourette's Syndrome
• Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension
• Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents
• Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19
• Selective Microbiota Transplantation for Tourette's Syndrome
• Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome
• Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder
• Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder
• A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)
• Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents
• Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder
• Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome
• Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome
• Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents
• Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
• Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
• Safety and Efficacy of Cannabis in Tourette Syndrome
• Effects of Ondansetron in Obsessive-compulsive and Tic Disorders
• CANNAbinoids in the Treatment of TICS (CANNA-TICS)
• Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome
• A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome
• Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome
• Safety and Efficacy Study of NBI-98854 in Children and Adolescents With Tourette Syndrome
• A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)
• Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo
• Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
• Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
• A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome
• Pilot Study for Use of Dysport in Treatment of Vocal Tics in Patients With Tourette's Syndrome
• FAAH Inhibitor Trial for Adults With Tourette Syndrome
• Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
• Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder
• Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
• Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
• Open-Trial of EPI-743 for Adults With Tourette Syndrome
• Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder
• Guanfacine in Children With Tic Disorders
• Phase III Study of 5LGr to Treat Tic Disorder
• Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome
• Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)
• Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
• Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
• Omega-3 Fatty Acids in Tourette's Disorder
• Ecopipam Treatment of Tourette Syndrome
• N-acetylcysteine (NAC) for Children With Tourette Syndrome
• A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome
• Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission
• Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder
• Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette Syndrome
• Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)
• Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria
• Methylphenidate for Treating Children With ADHD and Tourette Syndrome
• Comparison of Keppra and Clonidine in the Treatment of Tics
• Aripiprazole in the Treatment of Tourette's Syndrome
• Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
• Safety Study of Galantamine in Tic Disorders
• An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.
• A Randomized, Placebo-controlled, Tourette Syndrome Study.
• Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD
• Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome
• Randomized Study of Pergolide in Children With Tourette Syndrome
• Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder